Moderna, Inc. (MRNA)
52.56
-0.83
(-1.55%)
USD |
NASDAQ |
Mar 13, 16:00
52.50
-0.06
(-0.11%)
After-Hours: 20:00
Moderna EPS Diluted (Quarterly) : -2.107 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| Arbutus Biopharma Corp. | -0.0404 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -826.00M |
| Revenue (Quarterly) | 678.00M |
| Total Expenses (Quarterly) | 1.504B |
| Enterprise Value | 16.26B |
| Gross Profit Margin (Quarterly) | 23.45% |
| Profit Margin (Quarterly) | -121.8% |
| Earnings Yield | -13.82% |
| Normalized Earnings Yield | -13.82 |